flutrimazole
This page covers all flutrimazole drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nuclear receptor subfamily 1 group I member 2, Bile acid receptor.
Targets
Nuclear receptor subfamily 1 group I member 2, Bile acid receptor
Phase 2 pipeline (1)
- FLUTRIMAZOLE · Metabolic
Flutrimazole works by binding to and activating the nuclear receptor subfamily 1 group I member 2, which plays a role in regulating gene expression.
Patent intelligence
- flutrimazole patent landscape — aggregated cliff calendar, attackable patents, originator estates